StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
668
This year
10
Publishing Date
2021 - 05 - 17
8
2021 - 05 - 13
9
2021 - 05 - 12
10
2021 - 05 - 11
9
2021 - 05 - 10
8
2021 - 05 - 05
6
2021 - 05 - 04
19
2021 - 05 - 03
18
2021 - 04 - 27
5
2021 - 04 - 26
9
2021 - 04 - 23
7
2021 - 04 - 22
18
2021 - 04 - 21
9
2021 - 04 - 20
10
2021 - 04 - 19
9
2021 - 04 - 16
6
2021 - 04 - 15
11
2021 - 04 - 13
10
2021 - 04 - 12
7
2021 - 04 - 08
10
2021 - 04 - 06
6
2021 - 03 - 29
9
2021 - 03 - 24
7
2021 - 03 - 23
10
2021 - 03 - 22
8
2021 - 03 - 18
10
2021 - 03 - 17
11
2021 - 03 - 15
12
2021 - 03 - 12
6
2021 - 03 - 11
8
2021 - 03 - 10
5
2021 - 03 - 05
5
2021 - 03 - 01
5
2021 - 02 - 25
7
2021 - 02 - 24
5
2021 - 02 - 22
6
2021 - 02 - 12
7
2021 - 02 - 03
4
2021 - 02 - 01
12
2021 - 01 - 29
7
2021 - 01 - 27
7
2021 - 01 - 19
9
2021 - 01 - 15
6
2021 - 01 - 14
7
2021 - 01 - 12
4
2021 - 01 - 06
6
2021 - 01 - 05
7
2021 - 01 - 04
7
2020 - 12 - 28
4
2020 - 12 - 22
5
2020 - 12 - 21
10
2020 - 12 - 18
4
2020 - 12 - 17
4
2020 - 12 - 15
6
2020 - 12 - 11
9
2020 - 12 - 10
4
2020 - 12 - 08
6
2020 - 12 - 04
9
2020 - 12 - 03
6
2020 - 12 - 02
6
Sector
Commercial services
15
Consumer durables
7
Consumer non-durables
1
Consumer services
1
Distribution services
5
Electronic technology
2
Finance
6
Health care and social assistance
1
Health services
24
Health technology
668
Manufacturing
11
N/a
4
Process industries
10
Producer manufacturing
1
Professional, scientific, and technical services
4
Technology services
9
Tags
Alliances
1015
Application
1097
Approval
1291
Biopharma
1358
Bioscience
1262
Biotech
1224
Biotech-bay
1446
Biotech-beach
1241
Biotechnology
937
Business
1170
Cancer
3047
Clinical-trials-phase-ii
924
Collaboration
1160
Conference
7884
Covid
1464
Covid-19
1115
Disease
2082
Drug
2184
Earnings
2783
Europe
1283
Events
3544
Fda
2879
Financial
4729
Financial results
3239
Genetown
1534
Global
3071
Grant
988
Granted
874
Grants
896
Growth
2785
Health
1943
Market
5895
Medical
1126
Meeting
1476
N/a
49632
Nasdaq
1533
Offering
1845
People
1839
Pharm-country
1547
Pharma
2026
Pharmaceutical
869
Pharmaceuticals
2383
Phase 1
1024
Phase 2
1476
Phase 3
1220
Positive
1947
Preclinical
906
Presentation
1805
Report
3953
Research
4568
Results
11953
Study
1654
Technology
1036
Therapeutics
6976
Therapy
2313
Treatment
4038
Trial
4271
Update
2300
Vaccine
1461
Year
1624
Entities
Abbott laboratories
5
Abbvie inc.
4
Adc therapeutics sa
3
Agenus inc.
3
Agilent technologies, inc.
6
Amgen inc.
6
Anixa biosciences, inc.
5
Avinger, inc.
5
Avrobio, inc.
3
Axonics modulation technologies, inc.
3
Aytu bioscience, inc.
3
Becton, dickinson and company
5
Beigene, ltd.
9
Bio-techne corp
8
Boston scientific corporation
4
Bristol-myers squibb company
14
Bruker corporation
8
Cardiovascular systems, inc.
3
Caredx, inc.
6
Castle biosciences, inc.
3
Co-diagnostics, inc.
4
Edesa biotech, inc.
3
Eli lilly and company
17
Endo international plc
4
Essa pharma inc.
3
Exelixis, inc.
5
Genprex, inc.
3
Gilead sciences, inc.
3
Glaxosmithkline plc
4
Hoth therapeutics, inc.
5
I-mab
6
Incyte corporation
7
Johnson & johnson
57
Lexaria bioscience corp
4
Lineage cell therapeutics, inc.
3
Lipocine inc.
4
Masimo corporation
3
Medtronic plc
7
Merck & company, inc.
9
Mirum pharmaceuticals, inc.
3
Moderna, inc.
13
Moleculin biotech, inc.
3
Motus gi holdings, inc.
4
Myriad genetics, inc.
4
Nanostring technologies, inc.
3
Nanovibronix, inc.
4
Novartis ag
5
Novavax, inc.
3
Novo nordisk a/s
3
Omeros corporation
4
Perkinelmer, inc.
4
Pfizer, inc.
10
Quidel corporation
4
Sanofi
36
Seelos therapeutics, inc.
6
Takeda pharmaceutical company limited
10
Thermo fisher scientific inc
5
Tonix pharmaceuticals holding corp.
4
Twist bioscience corporation
9
Xencor, inc.
4
Symbols
A
6
ABBV
4
ABT
5
ADCT
3
AGEN
3
AMGN
6
ANIX
5
AVGR
5
AVRO
3
AXNX
3
AYTU
3
BDX
5
BGNE
9
BMY
14
BRKR
8
BSX
4
CDNA
6
CODX
4
CSII
3
CSTL
3
EDSA
3
ENDP
4
EPIX
3
EXEL
5
GILD
3
GNPX
3
GSK
4
HOTH
5
IMAB
6
INCY
7
JNJ
57
LCTX
3
LEXX
4
LLY
17
LPCN
4
MASI
3
MBRX
3
MDT
7
MIRM
3
MOTS
4
MRK
9
MRNA
13
MYGN
4
NAOV
4
NSTG
3
NVAX
3
NVS
5
OMER
4
PFE
10
PKI
4
QDEL
4
SEEL
6
SNY
36
SNYNF
6
TAK
10
TECH
8
TMO
5
TNXP
4
TWST
9
XNCR
4
Exchanges
Amex
17
Nasdaq
498
Nyse
187
Crawled Date
2021 - 05 - 17
8
2021 - 05 - 13
9
2021 - 05 - 12
10
2021 - 05 - 11
9
2021 - 05 - 10
8
2021 - 05 - 05
6
2021 - 05 - 04
19
2021 - 05 - 03
18
2021 - 04 - 27
5
2021 - 04 - 26
9
2021 - 04 - 23
7
2021 - 04 - 22
18
2021 - 04 - 21
9
2021 - 04 - 20
10
2021 - 04 - 19
9
2021 - 04 - 16
6
2021 - 04 - 15
12
2021 - 04 - 13
10
2021 - 04 - 12
7
2021 - 04 - 08
10
2021 - 04 - 06
6
2021 - 03 - 29
10
2021 - 03 - 24
7
2021 - 03 - 23
10
2021 - 03 - 22
8
2021 - 03 - 18
10
2021 - 03 - 17
11
2021 - 03 - 15
12
2021 - 03 - 12
6
2021 - 03 - 11
8
2021 - 03 - 10
5
2021 - 03 - 05
5
2021 - 03 - 01
5
2021 - 02 - 25
7
2021 - 02 - 24
5
2021 - 02 - 22
6
2021 - 02 - 12
7
2021 - 02 - 03
4
2021 - 02 - 01
12
2021 - 01 - 29
5
2021 - 01 - 27
7
2021 - 01 - 19
9
2021 - 01 - 15
6
2021 - 01 - 14
7
2021 - 01 - 12
4
2021 - 01 - 06
6
2021 - 01 - 05
7
2021 - 01 - 04
7
2020 - 12 - 28
4
2020 - 12 - 22
5
2020 - 12 - 21
10
2020 - 12 - 18
4
2020 - 12 - 17
4
2020 - 12 - 15
6
2020 - 12 - 11
8
2020 - 12 - 10
4
2020 - 12 - 08
6
2020 - 12 - 04
8
2020 - 12 - 03
6
2020 - 12 - 02
6
Crawled Time
00:00
5
01:00
1
05:00
3
06:00
7
07:00
9
08:00
8
09:00
10
10:00
11
10:41
2
11:00
19
12:00
111
12:01
1
12:15
19
12:20
3
12:30
5
12:39
4
13:00
66
13:13
2
13:15
16
13:20
5
13:30
4
13:35
5
13:40
1
14:00
68
14:15
3
14:20
4
14:30
2
15:00
85
15:15
1
15:20
1
15:30
2
16:00
45
17:00
46
18:00
29
19:00
18
20:00
13
21:00
15
22:00
6
23:00
13
Source
www.biospace.com
668
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
tags :
Product-news
save search
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Published:
2024-03-26
(Crawled : 20:00)
- biospace.com/
ENDPQ
|
$0.0006
-50.0%
3.4K
|
n/a
|
700.0%
|
O:
-40.0%
H:
33.33%
C:
0.0%
duexis
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Published:
2024-03-26
(Crawled : 18:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.43%
|
O:
1.84%
H:
0.24%
C:
-0.14%
adzynma
japan
takeda
approval
injection
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
Published:
2024-03-26
(Crawled : 12:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.95%
|
O:
0.01%
H:
0.0%
C:
0.0%
PTGX
|
$25.61
1.55%
1.52%
450K
|
Health Technology
|
-8.17%
|
O:
1.9%
H:
0.0%
C:
-1.48%
update
therapeutics
BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
Published:
2024-03-21
(Crawled : 12:00)
- biospace.com/
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
-1.58%
|
O:
0.46%
H:
1.26%
C:
1.11%
health
care
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Published:
2024-03-13
(Crawled : 11:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-7.18%
|
O:
1.0%
H:
1.41%
C:
-0.25%
disease
pneumococcal
children
Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
Published:
2024-02-29
(Crawled : 17:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.18%
|
O:
0.56%
H:
0.12%
C:
-0.38%
stelara
biosimilar
market
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Published:
2024-02-19
(Crawled : 09:00)
- biospace.com/
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
lung
license
cancer
cell
application
advanced
InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Greater Bay Area’s Early Access Program
Published:
2024-01-22
(Crawled : 07:00)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-6.42%
|
O:
0.56%
H:
1.97%
C:
1.37%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
96.07%
|
O:
0.11%
H:
1.96%
C:
-0.27%
first
bay
program
Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck
Published:
2024-01-18
(Crawled : 11:00)
- biospace.com/
AGEN
|
$5.3
6.64%
6.23%
1.5M
|
Health Technology
|
792.59%
|
O:
1.78%
H:
0.88%
C:
-6.95%
obt076
first
trial
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
Published:
2024-01-17
(Crawled : 14:30)
- biospace.com/
XBIO
|
$4.14
7.32%
770
|
Health Technology
|
14.75%
|
O:
0.0%
H:
0.0%
C:
-4.37%
research
agreement
platform
LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
Published:
2023-12-26
(Crawled : 06:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.69%
|
O:
-0.16%
H:
0.0%
C:
0.0%
lcb84
license
agreement
Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries
Published:
2023-12-20
(Crawled : 14:00)
- biospace.com/
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
4.44%
|
O:
1.22%
H:
0.85%
C:
-1.62%
research
platform
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
23.97%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.44%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-0.41%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Delaware Federal District Court Rules in Favor of Acadia Pharmaceuticals in NUPLAZID® (pimavanserin) Patent Litigation
Published:
2023-12-13
(Crawled : 20:00)
- biospace.com/
ACAD
|
$16.82
-1.47%
-1.49%
3.5M
|
Health Technology
|
-20.55%
|
O:
1.56%
H:
34.6%
C:
32.42%
nuplazid
patent
pharmaceuticals
Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List
Published:
2023-12-13
(Crawled : 15:30)
- biospace.com/
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-47.4%
|
O:
4.67%
H:
10.29%
C:
6.86%
nuzyra
drug
pharmaceuticals
European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
Published:
2023-12-08
(Crawled : 21:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-9.19%
|
O:
0.07%
H:
1.1%
C:
0.45%
elrexfio
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry DiseasePatient enrollment expected to begin in first half of 2024
Published:
2023-11-29
(Crawled : 14:30)
- biospace.com/
QURE
|
$4.68
-0.64%
-0.64%
550K
|
Health Technology
|
-33.09%
|
O:
0.0%
H:
4.58%
C:
-2.58%
amt-191
fda
drug
expected
clearance
application
therapy
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability
Published:
2023-11-28
(Crawled : 15:00)
- biospace.com/
NVCR
|
$12.09
0.33%
0.33%
850K
|
Health Technology
|
1.51%
|
O:
0.0%
H:
3.78%
C:
2.43%
growth
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
Published:
2023-11-17
(Crawled : 22:00)
- biospace.com/
MASI
|
$134.77
-0.85%
-0.85%
350K
|
Health Technology
|
44.82%
|
O:
0.09%
H:
1.29%
C:
0.7%
fda
clearance
medical
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published:
2023-11-17
(Crawled : 16:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-31.53%
|
O:
0.0%
H:
0.38%
C:
-1.21%
brukinsa
approval
treatment
← Previous
1
2
3
4
5
6
7
8
9
…
33
34
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.